Publikationen von Sabrina Kraft

Rossnagl, S.; Altrock, E.; Sens, C.; Kraft, S.; Rau, K.; Milsom, M. D.; Giese, T.; Samstag, Y.; Nakchbandi, I. A.: EDA-Fibronectin Originating from Osteoblasts Inhibits the Immune Response against Cancer. PLoS Biology 14 (9), e1002562 (2016)

Kraft, S.; Klemis, V.; Sens, C.; Lenhard, T.; Jacobi, C.; Samstag, Y.; Wabnitz, G.; Kirschfink, M.; Wallich, R.; Hänsch, G. M. et al.; Nakchbandi, I. A.: Identification and characterization of a unique role for EDB fibronectin in phagocytosis. JOURNAL OF MOLECULAR MEDICINE-JMM 94 (5), S. 567 - 581 (2016)

von Au, A.; Vasel, M.; Kraft, S.; Sens, C.; Hackl, N.; Marx, A.; Stroebel, P.; Hennenlotter, J.; Todenhoefer, T.; Stenzl, A. et al.; Schott, S.; Sinn, H.-P.; Wetterwald, A.; Bermejo, J. L.; Cecchini, M. G.; Nakchbandi, I. A.: Circulating Fibronectin Controls Tumor Growth. NEOPLASIA 15 (8), S. 925 - 938 (2013)

von Au, A.; Vasel, M.; Kraft, S.; Cecchini, M. G.; Wetterwald, A.; Nakchbandi, I.: Circulating fibronectin increases tumor growth and fibronectin content of tumors correlates with survival. In Bone, 50 (Suppl. 1), S. S50 - S51. ELSEVIER SCIENCE INC, NEW YORK (2012)

Kawelke, N.; Kraft, S.; Vasel, M.; Nakchbandi, I. A.: Beta1 integrin expression in osteoblast progenitors is required for bone formation. In Bone, 48 (Suppl. 2), S. S118 - S118. ELSEVIER SCIENCE INC, NEW YORK (2011)